Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

2,001

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

November 6, 2024

Study Completion Date

November 6, 2024

Conditions
PoliomyelitisVaccine Reaction
Interventions
BIOLOGICAL

Eupolio

Inactivated Polio vaccine (Sabin strains)

Trial Locations (10)

Unknown

Health Index Multispecialty and Lying-in Clinic, Cavite City

De La Salle Medical and Health Sciences Institue, Gov, D, Nabgybat Ave

University of the Philippines - Philippine General Hospital, Manila

Tropical Disease Foundateion, Inc., Metro Manila

Philippine Heart Center, Quezon City

Faculty of Medicine, Chulalongkorn University, Bangkok

Siriraj hospital, Bangkok

Faculty of Medicine, Chiang Mai University, Chiang Mai

Khon Kaen University, Srinagarind Hospital, Khon Kaen

Hatyai Hospital, Songkhla

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LG Chem

INDUSTRY

NCT05431933 - Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in Infants | Biotech Hunter | Biotech Hunter